Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allot Ltd. stock logo
ALLT
Allot
$7.31
-6.8%
$8.47
$6.12
▼
$11.92
$385.55M1.51462,761 shs430,467 shs
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
$5.73
-10.5%
$8.68
$5.72
▼
$24.23
$1.01B2.365.79 million shs7.41 million shs
AeroVironment, Inc. stock logo
AVAV
AeroVironment
$86.79
-9.5%
$130.54
$86.20
▼
$408.25
$5.56B1.421.34 million shs1.93 million shs
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
$0.68
+0.6%
$0.98
$0.57
▼
$6.88
$119.13M1.062.01 million shs1.82 million shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allot Ltd. stock logo
ALLT
Allot
-6.76%-8.05%-19.32%-2.27%-14.40%
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
-10.54%-27.79%-31.17%-44.64%-47.25%
AeroVironment, Inc. stock logo
AVAV
AeroVironment
-9.51%-26.15%-26.14%-45.83%-69.05%
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
+0.81%-11.61%-16.02%-71.50%-86.04%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allot Ltd. stock logo
ALLT
Allot
$7.31
-6.8%
$8.47
$6.12
▼
$11.92
$385.55M1.51462,761 shs430,467 shs
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
$5.73
-10.5%
$8.68
$5.72
▼
$24.23
$1.01B2.365.79 million shs7.41 million shs
AeroVironment, Inc. stock logo
AVAV
AeroVironment
$86.79
-9.5%
$130.54
$86.20
▼
$408.25
$5.56B1.421.34 million shs1.93 million shs
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
$0.68
+0.6%
$0.98
$0.57
▼
$6.88
$119.13M1.062.01 million shs1.82 million shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allot Ltd. stock logo
ALLT
Allot
-6.76%-8.05%-19.32%-2.27%-14.40%
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
-10.54%-27.79%-31.17%-44.64%-47.25%
AeroVironment, Inc. stock logo
AVAV
AeroVironment
-9.51%-26.15%-26.14%-45.83%-69.05%
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
+0.81%-11.61%-16.02%-71.50%-86.04%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allot Ltd. stock logo
ALLT
Allot
2.71
Moderate Buy$13.2481.12% Upside
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
2.86
Moderate Buy$20.50257.77% Upside
AeroVironment, Inc. stock logo
AVAV
AeroVironment
2.77
Moderate Buy$217.30150.37% Upside
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
2.76
Moderate Buy$9.991,360.77% Upside

Current Analyst Ratings Breakdown

Latest CMPX, AVAV, ALLT, and AMPX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/17/2026
Allot Ltd. stock logo
ALLT
Allot
UpgradeSell (D+) ➝ Hold (C-)
11/17/2026
Allot Ltd. stock logo
ALLT
Allot
Lower Price TargetBuy$13.90 ➝ $12.70
11/12/2026
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
Reiterated RatingBuy
11/12/2026
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
Lower Price TargetBuy$22.00 ➝ $16.00
11/11/2026
AeroVironment, Inc. stock logo
AVAV
AeroVironment
Reiterated RatingOutperform
11/11/2026
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
Lower Price TargetBuy$20.00 ➝ $15.00
11/10/2026
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
Lower Price TargetNeutral$1.00 ➝ $0.90
11/6/2026
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
Reiterated RatingOutperform
11/6/2026
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
Reiterated RatingOutperform
11/2/2026
AeroVironment, Inc. stock logo
AVAV
AeroVironment
Reiterated RatingMarket Outperform
11/2/2026
AeroVironment, Inc. stock logo
AVAV
AeroVironment
Lower Price TargetOverweight$220.00 ➝ $200.00
(Data available from 11/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allot Ltd. stock logo
ALLT
Allot
$101.99M3.53$0.19 per share38.19$2.45 per share2.98
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
$73.01M11.12N/AN/A$0.88 per share6.51
AeroVironment, Inc. stock logo
AVAV
AeroVironment
$1.98B2.23$10.77 per share8.06$88.12 per share0.98
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
$850K144.92N/AN/A$0.79 per share0.87
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allot Ltd. stock logo
ALLT
Allot
$3.70M$0.2233.2327.07N/A9.58%9.86%5.98%N/A
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
-$44.02M-$0.28N/AN/AN/A-29.94%-11.71%-9.03%N/A
AeroVironment, Inc. stock logo
AVAV
AeroVironment
-$265.12M-$2.34N/A20.761.72-5.77%4.04%3.13%12/8/2026 (Estimated)
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
-$66.49M-$0.47N/AN/AN/AN/A-49.93%-43.76%N/A

Latest CMPX, AVAV, ALLT, and AMPX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
12/8/2026Q2 2027
AeroVironment, Inc. stock logo
AVAV
AeroVironment
$0.4175N/AN/AN/A$510.62 millionN/A
11/12/2026Q3 2026
Allot Ltd. stock logo
ALLT
Allot
$0.0895$0.09+$0.0005$0.07$30.03 million$30.59 million
11/10/2026Q3 2026
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
-$0.0127-$0.0240-$0.0113-$0.0240$35.80 million$39.15 million
11/9/2026Q3 2026
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
-$0.1264-$0.15-$0.0236-$0.15$0.23 millionN/A
9/9/2026Q1 2027
AeroVironment, Inc. stock logo
AVAV
AeroVironment
$0.2223$0.59+$0.3677-$0.10$451.95 million$480.49 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Allot Ltd. stock logo
ALLT
Allot
N/AN/AN/AN/AN/A
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
N/AN/AN/AN/AN/A
AeroVironment, Inc. stock logo
AVAV
AeroVironment
N/AN/AN/AN/AN/A
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allot Ltd. stock logo
ALLT
Allot
N/A
2.22
1.99
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
N/A
4.21
3.74
AeroVironment, Inc. stock logo
AVAV
AeroVironment
0.17
4.26
3.33
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
N/A
6.79
6.79

Institutional Ownership

CompanyInstitutional Ownership
Allot Ltd. stock logo
ALLT
Allot
51.50%
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
5.04%
AeroVironment, Inc. stock logo
AVAV
AeroVironment
86.38%
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
68.43%

Insider Ownership

CompanyInsider Ownership
Allot Ltd. stock logo
ALLT
Allot
3.40%
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
5.10%
AeroVironment, Inc. stock logo
AVAV
AeroVironment
0.79%
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
18.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Allot Ltd. stock logo
ALLT
Allot
36249.30 million47.63 millionOptionable
Amprius Technologies, Inc. stock logo
AMPX
Amprius Technologies
109141.63 million134.40 millionOptionable
AeroVironment, Inc. stock logo
AVAV
AeroVironment
3,99150.82 million50.42 millionOptionable
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
39180.09 million146.41 millionOptionable

Recent News About These Companies

Contrasting Compass Therapeutics (CMPX) and Its Peers

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Allot stock logo

Allot NASDAQ:ALLT

$7.31 -0.53 (-6.76%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$7.26 -0.05 (-0.67%)
As of 11/20/2026 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Allot Communications Ltd. is a provider of leading innovative network intelligence and security solutions for service providers worldwide, enhancing value to their customers. Their solutions are deployed globally for network and application analytics, traffic control and shaping, network-based security services, and more. Allot's multi-service platforms are deployed by over 500 mobile, fixed and cloud service providers and over 1000 enterprises. Their industry leading network-based security as a service solution has achieved over 50% penetration with some service providers and is already used by over 20 million subscribers in Europe.

Amprius Technologies stock logo

Amprius Technologies NYSE:AMPX

$5.73 -0.67 (-10.47%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$5.89 +0.16 (+2.81%)
As of 11/20/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Amprius Technologies, Inc. produces and sells ultra-high energy density lithium-ion batteries for mobility applications. The company offers silicon nanowire anode batteries. Its batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. The company was incorporated in 2008 and is headquartered in Fremont, California.

AeroVironment stock logo

AeroVironment NASDAQ:AVAV

$86.79 -9.12 (-9.51%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$89.09 +2.30 (+2.65%)
As of 11/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AeroVironment, Inc. designs, develops, produces, delivers, and supports a portfolio of robotic systems and related services for government agencies and businesses in the United States and internationally. It operates through Small Unmanned Aircraft Systems (SUAS), Tactical Missile System (TMS), Medium Unmanned Aircraft Systems (MUAS), and High Altitude Pseudo-Satellite Systems (HAPS) segments. The company supplies UAS, TMS, unmanned ground vehicle, and related services primarily to organizations within the U.S. Department of Defense, other federal agencies, and to international allied governments. It also designs, engineers, tools, and manufactures unmanned aerial and aircraft systems, including airborne platforms, payloads and payload integration, ground control systems, and ground support equipment and other items and services related to unmanned aircraft systems. In addition, the company offers small UAS products, including training, spare parts, product repair, product replacement, and the customer contracted operation. Further, it develops high-altitude pseudo-satellite UAS systems. AeroVironment, Inc. was incorporated in 1971 and is headquartered in Arlington, Virginia.

Compass Therapeutics stock logo

Compass Therapeutics NASDAQ:CMPX

$0.68 +0.00 (+0.59%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$0.68 0.00 (0.00%)
As of 11/20/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. The company's lead product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. The company was founded in 2014 and is headquartered in Boston, Massachusetts.